ERBB2 and neoplasm: Several oncogenic signaling pathways, including Src/STAT3, EGFR, HER2, MAPK, AKT/mTOR, WNT/-catenin and miRNA-related pathways, have been associated with changes in tumor cell surface CD24 expression [8].